Literature DB >> 16178871

Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood.

S Toyabe1, U Kaneko, M Hara, M Uchiyama.   

Abstract

Concanavarin-A (conA)-stimulated peripheral blood mononuclear cells (PBMNC) from patients with idiopathic nephrotic syndrome (INS) produce putative factors that increase vascular permeability. These factors are expressed in the nephrotic phase but are reduced in the convalescent phase. To identify the genes that are expressed only in the nephrotic phase, we performed cDNA subtraction using conA-stimulated PBMNC from three patients with INS. We isolated several gene transcripts in all three subtracted cDNA libraries. Among these genes, IgE-dependent histamine-releasing factor (HRF) was overexpressed in the nephrotic phase not only at the mRNA level but also at the protein level in another 10 patients with INS. Moreover, we found increased secretion of HRF from conA-stimulated PBMNC in the nephrotic phase. The results suggest that HRF is involved in the pathogenesis of idiopathic nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16178871      PMCID: PMC1809496          DOI: 10.1111/j.1365-2249.2005.02890.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening.

Authors:  Djillali Sahali; André Pawlak; Asta Valanciuté; Philippe Grimbert; Philippe Lang; Philippe Remy; Albert Bensman; Georges Guellën
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 2.  Circulating mediators of proteinuria in idiopathic minimal lesion nephrotic syndrome.

Authors:  E H Garin
Journal:  Pediatr Nephrol       Date:  2000-08       Impact factor: 3.714

3.  Recombinant histamine-releasing factor enhances IgE-dependent IL-4 and IL-13 secretion by human basophils.

Authors:  J T Schroeder; L M Lichtenstein; S M MacDonald
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

4.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.

Authors:  R Bheekha-Escura; D W MacGlashan; J M Langdon; S M MacDonald
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

6.  Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor.

Authors:  R Bheekha-Escura; S R Chance; J M Langdon; D W MacGlashan; S M MacDonald
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

7.  Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.

Authors:  Shin Okuyama; Atsushi Komatsuda; Hideki Wakui; Namiko Aiba; Naohito Fujishima; Keiko Iwamoto; Hiroshi Ohtani; Ken-ichi Sawada
Journal:  Nephrol Dial Transplant       Date:  2005-01-25       Impact factor: 5.992

8.  Molecular identification of an IgE-dependent histamine-releasing factor.

Authors:  S M MacDonald; T Rafnar; J Langdon; L M Lichtenstein
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

9.  Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome.

Authors:  J Dantal; E Bigot; W Bogers; A Testa; F Kriaa; Y Jacques; B Hurault de Ligny; P Niaudet; B Charpentier; J P Soulillou
Journal:  N Engl J Med       Date:  1994-01-06       Impact factor: 91.245

10.  An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils.

Authors:  J T Schroeder; L M Lichtenstein; S M MacDonald
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  2 in total

1.  Minimal change nephrotic syndrome in a patient with strongyloidiasis.

Authors:  Mieko Miyazaki; Masahito Tamura; Narutoshi Kabashima; Ryota Serino; Tatsuya Shibata; Tetsu Miyamoto; Yumi Furuno; Tetsuo Nishio; Jiro Ohara; Toshihiro Sakurai; Yutaka Otsuji
Journal:  Clin Exp Nephrol       Date:  2010-03-12       Impact factor: 2.801

2.  Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report.

Authors:  Tahereh Malakoutian; Ronak Mohammadi; Mojgan Asgari; Atefeh Amouzegar
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.